Achieve Life Sciences, Inc. · NASDAQ:ACHV
Vivo Opportunity, LLC reported a 5.00% stake in Achieve Life Sciences, Inc. (Schedule 13G)
Event Jul 6, 2026 · Filed Jul 8, 2026
Vivo Opportunity, LLC reported a 5.00% stake in Achieve Life Sciences, Inc., 5,305,640 shares, as a passive investor on Jul 6, 2026. Filed Jul 8, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 5,305,640
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 1.80% | 1,944,430 |
| Vivo Opportunity Co-Invest, L.P. | 1.20% | 1,220,358 |
| Vivo Opportunity Co-Invest (Cycle 3), L.P. | 2.00% | 2,140,852 |
| Vivo Opportunity, LLC | 5.00% | 5,305,640 |
| Vivo Opportunity Cayman Fund, L.P. | 0.20% | 196,424 |
| Vivo Opportunity Cayman, LLC | 0.20% | 196,424 |
Source
Related
- Achieve Life Sciences, Inc.
- Vivo Opportunity, LLC
- Achieve Life Sciences, Inc. shareholders
- Form 4 · Stewart Richard Alistair · Aug 21, 2026
- Schedule 13G · Logos Global Management LP · Aug 17, 2026
- Schedule 13G · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Franklin Resources Inc · Jul 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026